ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026
Safety of gonioscopy-assisted transluminal trabeculotomy without antithrombotic discontinuation versus no antithrombotic therapy: a large cohort study.
Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the influence of antithrombotic agent use on early postoperative complications and surgical success.
methodsA retrospective, single-center study including all patients who underwent GATT between December 2019 and December 2023 with at least three months follow-up. Pre-operative characteristics, post-operative complications and surgical success were compared between the antithrombotic (AT) and the non-antithrombotic (NAT) groups.
resultsAntithrombotic agents were used in 139 of the 444 cases (31.3%). 73% of the antithrombotic agents were anti platelet COX-1 inhibitors. Patients in the AT group were older (75 ± 7.6 vs. 66.6 ± 17.2; P < 0.01) and had a lower maximal intraocular pressure (IOP) (28.6 ± 10.3 vs. 34.7 ± 11; P < 0.01). There were no differences between the AT and NAT groups in rates of microhyphema and layered hyphema (85% vs. 89%; P = 0.3), duration of hyphema (7.98 ± 8.4 vs. 8.7 ± 8.6; P = 0.4), and presence of anterior chamber clots (22.2% vs. 24%; P = 0.7). There was also no difference in the incidence of IOP spikes (23.9% vs. 21.6%; P = 0.6), or in overall surgical success (77.6% vs. 77.3%; P = 0.5) on last follow-up. Patients in the AT group underwent fewer additional surgeries to control IOP compared to the NAT group (4.3% vs. 10.1%; P = 0.04).
conclusionsThere were no significant differences in bleeding prevalence or duration between patients receiving antithrombotic therapy and those not receiving it prior to GATT. These results suggest that continuation of antithrombotic therapy during GATT may be reasonable in selected patients, following individualized assessment of systemic and ocular risk.
Indexed as
Identifiers
42576032What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.